The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study
Open accessAbstract
BACKGROUND: Primary aldosteronism is a nonsuppressible renin-independent aldosterone production that causes hypertension and cardiovascular disease. OBJECTIVE: To characterize the prevalence of nonsuppressible renin-independent aldosterone production, as well as biochemically overt primary aldosteronism, in relation to blood pressure. DESIGN: Cross-sectional study. SETTING: 4 U.S. academic medical centers. PARTICIPANTS: = 408). MEASUREMENTS: Participants completed an oral sodium suppression test, regardless of aldosterone or renin levels, as a confirmatory diagnostic for primary aldosteronism and to quantify the magnitude of renin-independent aldosterone production. Urinary aldosterone was measured in participants in high sodium balance with suppressed renin activity. Biochemically overt primary aldosteronism was diagnosed when urinary aldosterone levels were higher than 12 μg/24 h. RESULTS: Every blood pressure category had a continuum of renin-independent aldosterone production, where greater severity of production was associated with higher blood pressure, kaliuresis, and lower serum potassium levels. Mean adjusted levels of urinary aldosterone were 6.5 μg/24 h (95% CI, 5.2 to 7.7 μg/24 h) in normotension, 7.3 μg/24 h (CI, 5.6 to 8.9 μg/24 h) in stage 1 hypertension, 9.5 μg/24 h (CI, 8.2 to 10.8 μg/24 h) in stage 2 hypertension, and 14.6 μg/24 h (CI, 12.9 to 16.2 μg/24 h) in resistant hypertension; corresponding adjusted prevalence estimates for biochemically overt primary aldosteronism were 11.3% (CI, 5.9% to 16.8%), 15.7% (CI, 8.6% to 22.9%), 21.6% (CI, 16.1% to 27.0%), and 22.0% (CI, 17.2% to 26.8%). The aldosterone-renin ratio had poor sensitivity and negative predictive value for detecting biochemically overt primary aldosteronism. LIMITATION: Prevalence estimates rely on arbitrary and conventional thresholds, and the study population may not represent nationwide demographics. CONCLUSION: The prevalence of primary aldosteronism is high and largely unrecognized. Beyond this categorical definition of primary aldosteronism, there is a prevalent continuum of renin-independent aldosterone production that parallels the severity of hypertension. These findings redefine the primary aldosteronism syndrome and implicate it in the pathogenesis of "essential" hypertension. PRIMARY FUNDING SOURCE: National Institutes of Health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citationMills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016) · Circulation · doi:10.1161/circulationaha.115.018912 · Cited by 3,531
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Self-citationA prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Williams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., Ford, I., Cruickshank, J. K., Caulfield, M. J., Salsbury, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00257-3 · Cited by 1,308
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Self-citationMonticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.06.010 · Cited by 947
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000597 · Cited by 902
Self-citationUrinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events
O'Donnell, M., Mente, A., Rangarajan, S., McQueen, M. J., Wang, X., Liu, L., Yan, H., Lee, S. F., Mony, P., Devanath, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311889 · Cited by 886
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Monticone, S., Burrello, J., Tizzani, D., Bertello, C., Viola, A., Buffolo, F., Gabetti, L., Mengozzi, G., Williams, T. A., Rabbia, F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.052 · Cited by 882
Association of Urinary Sodium and Potassium Excretion with Blood Pressure
Mente, A., O'Donnell, M. J., Rangarajan, S., McQueen, M. J., Poirier, P., Wielgosz, A., Morrison, H., Li, W., Wang, X., Di, C., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311989 · Cited by 858
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30367-4 · Cited by 677
Self-citationSerum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571
Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment
Catena, C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.33 · Cited by 565
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562
Primary Aldosteronism and Hypertensive Disease
Mosso, L., Carvajal, C., González, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A., & Fardella, C. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000079505.25750.11 · Cited by 488
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 415
Huang, L., Trieu, K., Yoshimura, S., Neal, B., Woodward, M., Campbell, N. R. C., Li, Q., Lackland, D. T., Leung, A. A., Anderson, C. A. M., et al. (2020) · BMJ · doi:10.1136/bmj.m315 · Cited by 403
Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30071-8 · Cited by 347
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands
Nishimoto, K., Tomlins, S. A., Kuick, R., Cani, A. K., Giordano, T. J., Hovelson, D. H., Liu, C.-J., Sanjanwala, A. R., Edwards, M. A., Gomez-Sanchez, C. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505529112 · Cited by 334
Vaidya, A., Mulatero, P., Baudrand, R., & Adler, G. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00139 · Cited by 299
Self-citationStowasser, M., Gordon, R. D., Gunasekera, T. G., Cowley, D. C., Ward, G., Archibald, C., & Smithers, B. M. (2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00025 · Cited by 280
Normokalemic Primary Aldosteronism: A Detectable Cause of Curable "Essential" Hypertension
Conn, J. W. (1965) · JAMA · doi:10.1001/jama.1965.03090030022005 · Cited by 244
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study
Brown, J. M., Robinson-Cohen, C., Luque-Fernandez, M. A., Allison, M. A., Baudrand, R., Ix, J. H., Kestenbaum, B., de Boer, I. H., & Vaidya, A. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0882 · Cited by 221
Self-citationNewton-Cheh, C., Guo, C.-Y., Gona, P., Larson, M. G., Benjamin, E. J., Wang, T. J., Kathiresan, S., O’Donnell, C. J., Musone, S. L., Camargo, A. L., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000258554.87444.91 · Cited by 218
Continuum of Renin-Independent Aldosteronism in Normotension
Baudrand, R., Guarda, F. J., Fardella, C., Hundemer, G., Brown, J., Williams, G., & Vaidya, A. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08952 · Cited by 202
Self-citationSuppressed Plasma Renin Activity in Essential Hypertension
JOSE, A., Crout, J. R., & Kaplan, N. M. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-1-9 · Cited by 194
Carey, R. M. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.130.6.849 · Cited by 173
Self-citationPrimary Aldosteronism: Practical Approach to Diagnosis and Management
Byrd, J. B., Turcu, A. F., & Auchus, R. J. (2018) · Circulation · doi:10.1161/circulationaha.118.033597 · Cited by 169
Rossi, G. P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.057 · Cited by 165
Screening Rates for Primary Aldosteronism in Resistant Hypertension: A Cohort Study
Jaffe, G., Gray, Z., Krishnan, G., Stedman, M., Zheng, Y., Han, J., Chertow, G. M., Leppert, J. T., & Bhalla, V. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14359 · Cited by 163
Burrello, J., Monticone, S., Losano, I., Cavaglià, G., Buffolo, F., Tetti, M., Covella, M., Rabbia, F., Veglio, F., Pasini, B., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14063 · Cited by 156
Omata, K., Anand, S. K., Hovelson, D. H., Liu, C., Yamazaki, Y., Nakamura, Y., Ito, S., Satoh, F., Sasano, H., Rainey, W. E., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00134 · Cited by 150
Tanabe, A., Naruse, M., Takagi, S., Tsuchiya, K., Imaki, T., & Takano, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021476 · Cited by 140
Racial Differences in Sensitivity of Blood Pressure to Aldosterone
Tu, W., Eckert, G. J., Hannon, T. S., Liu, H., Pratt, L. M., Wagner, M. A., DiMeglio, L. A., Jung, J., & Pratt, J. H. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02989 · Cited by 126
The Syndrome of Essential Hypertension and Suppressed Plasma Renin Activity
Carey, R. M. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.1972.03650060041007 · Cited by 124
Self-citationRole of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00072 · Cited by 119
Markou, A., Pappa, T., Kaltsas, G., Gouli, A., Mitsakis, K., Tsounas, P., Prevoli, A., Tsiavos, V., Papanastasiou, L., Zografos, G., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3353 · Cited by 112
Markou, Α., Sertedaki, A., Kaltsas, G., Androulakis, I. I., Marakaki, C., Παππά, Θ., Gouli, A., Papanastasiou, L., Fountoulakis, S., Zacharoulis, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1268 · Cited by 107
Hannemann, A., Bidlingmaier, M., Friedrich, N., Manolopoulou, J., Spyroglou, A., Völzke, H., Beuschlein, F., Seißler, J., Rettig, R., Felix, S. B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1013 · Cited by 103
Carey, R. M., Schoeffel, C. D., Gildea, J. J., Jones, J. E., McGrath, H. E., Gordon, L. N., Park, M., Sobota, R. S., UNDERWOOD, P. C., Williams, J. S., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196071 · Cited by 100
Self-citationKem, D. C., Weinberger, M. H., HIGGINS, J. R., et al. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-4-552 · Cited by 98
Siragy, H., Vieweg, W. R., Pincus, S., & Veldhuis, J. D. (1995) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.80.1.7829626 · Cited by 98
Dietary Sodium Restriction Increases the Risk of Misinterpreting Mild Cases of Primary Aldosteronism
Baudrand, R. F., Guarda, F. J., Torrey, J., Williams, G. H., & Vaidya, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1963 · Cited by 80
Self-citationKeeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives
Ruhle, B. C., White, M. G., Alsafran, S. K., Kaplan, E. L., Angelos, P., & Grogan, R. H. (2018) · Surgery · doi:10.1016/j.surg.2018.05.085 · Cited by 74
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension
Dudenbostel, T., Ghazi, L., Liu, M., Li, P., Oparil, S., & Calhoun, D. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07806 · Cited by 60
Self-citationPrimary aldosteronism and salt
Funder, J. W. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1658-0 · Cited by 56
Hannemann, A., Wallaschofski, H., Lüdemann, J., Völzke, H., Markus, M. R. P., Rettig, R., Lendeckel, U., Reincke, M., Felix, S. B., Empen, K., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.008 · Cited by 33
Temporal pattern of renin and aldosterone secretion in men: effects of sodium balance
Vieweg, W. V. R., Veldhuis, J. D., & Carey, R. M. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.262.5.f871 · Cited by 33
Self-citationKline, G. A., Darras, P., Leung, A. A. C., So, B., Chin, A., & Holmes, D. T. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001905 · Cited by 28
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives ∗
Maiolino, G., Calò, L. A., & Rossi, G. P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.041 · Cited by 24
Piazza, M., Seccia, T. M., Caroccia, B., Rossitto, G., Scarpa, R., Persichitti, P., Basso, D., & Rossi, G. P. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13388 · Cited by 24
Vecchiola, A., Fuentes, C., Barros, E., Martínez‐Aguayo, A., García, H., Allende, F. A., Solari, S., Olmos, R. I., Carvajal, C. A., Tapia-Castillo, A., et al. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz023 · Cited by 23
Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism
Williams, T. A., Jaquin, D., Burrello, J., Philippe, A., Yang, Y., Rank, P., Nirschl, N., Sturm, L., Hübener, C., Dragun, D., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13156 · Cited by 23
Grim, C. E. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0045-1 · Cited by 22
An Individualized Approach to The Evaluation and Management of Primary Aldosteronism
Vaidya, A., Malchoff, C. D., & Auchus, R. J. (2017) · Endocrine Practice · doi:10.4158/ep161717.ra · Cited by 21
Self-citation
Cited by
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Pathophysiology of Hypertension: The Mosaic Theory and Beyond
Harrison, D. G., Coffman, T. M., & Wilcox, C. S. (2021) · Circulation Research · doi:10.1161/circresaha.121.318082 · Cited by 365
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Adler, G. K., Stowasser, M., Correa, R. R., Khan, N., Kline, G., McGowan, M. J., Mulatero, P., Murad, M. H., Touyz, R. M., Vaidya, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf284 · Cited by 355
Self-citationDiagnosis and treatment of primary aldosteronism
Reincke, M., Bancos, I., Mulatero, P., Scholl, U. I., Stowasser, M., & Williams, T. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00210-2 · Cited by 354
Writing Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 310
Metadata
- Authors
- Brown, J. M., Siddiqui, M., Calhoun, D. A., Carey, R. M., Hopkins, P. N., Williams, G. H., & Vaidya, A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2020-07-07
- Volume
- 173
- Issue
- 1
- Pages
- 10-20
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W3171708529
- Cited by
- 649
- References
- 57
- FWCI
- 49.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.